Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

ESMO-CDDF – Regulatory challenges in clinical cancer drug development

Specifics of CHMP assessment of cancer drugs

Date

16 Sep 2024

Session

ESMO-CDDF – Regulatory challenges in clinical cancer drug development

Topics

Clinical Research

Tumour Site

Presenters

Aaron Sosa Mejia

Authors

A.E. Sosa Mejia

Author affiliations

  • Medical Oncology Department, Danish Medicines Agency, 2300 - Copenhagen/DK

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.